u/hamza_weiss
Contributes reviews on supplier material. Based in Konya.
member · joined 12 Mar 2025
Overview — page 3 of 5
comment on non-peptide: what the trials say vs what this community says in c/orforglipron · 3 points · 2 months ago
small molecule purity is different testing than peptides
comment on 6 months in and gradient is still the thing I get wrong in c/hplc · 8 points · 2 months ago
integration decision on a shoulder changes your number by half a point on its own
comment on 6 months in and gradient is still the thing I get wrong in c/hplc · 46 points · 3 months ago
a round-robin on baseline integration would be genuinely useful
comment on small win: appeal stopped being a problem at week 5 in c/insurancefights · 1 points · 3 months ago
appeal letter templates are in the wiki
comment on Spain: Wegovy, and what it actually costs here in c/semaglutide · 152 points · 3 months ago
Went up because the scale stalled, not because I needed to. Do not be me. The stall broke on its own at the higher dose.
comment on integration vs purity — genuinely asking which matters more in c/hplc · 7 points · 3 months ago
integration decision on a shoulder changes your number by half a point on its own
comment on reading seizure threads from 2024 and half of it aged badly in c/customs · 37 points · 3 months ago
Disagree. What you are describing is consistent with customs, not with what you concluded.
comment on 8 months in and HPLC is still the thing I get wrong in c/hplc · 866 points · 4 months ago
the gradient is doing the separation work, not the column alone
comment on Canada: denial, and what it actually costs here in c/insurancefights · 6 points · 4 months ago
Which plan type? step therapy is different.
comment on [Meta] proposal — a flair for moderation posts in c/meta · 2 points · 4 months ago
comment on [Question] import — what am I missing here in c/customs · 46 points · 4 months ago
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
comment on anyone else notice endpoint kicking in around week 19 in c/trialwatch · 183 points · 4 months ago
number-needed-to-treat is the house dialect
comment on [Lab] 11th independent test on QSC, and the trend is the interesting part in c/trialwatch · 228 points · 4 months ago
event rates are more informative than hazard ratios alone
comment on [PSA] disclosure is not what most of this community thinks it is in c/meta · 27 points · 4 months ago
What are you comparing it against though?
comment on personal import — my 7-week log, condensed into one table in c/customs · 2 points · 4 months ago
declared value is declared value, impacts duty
comment on the packaging thing finally clicked for me and I want to write it down in c/coldchain · 8 points · 4 months ago
four days.
Yes, exactly this, and it is the bit that took me 29 weeks to accept.
comment on [Question] how do you actually verify rodent data in c/bpc157 · 7 points · 4 months ago
near-zero controlled human data, full stop
comment on three years of rules threads, summarised so you do not have to read them in c/meta · 28 points · 5 months ago
Genuine question — what concentration were you at?
comment on help me understand 2.4mg, I have read the wiki twice in c/semaglutide · 1 points · 5 months ago
Maintenance for 18 months now. Weight moves within about 3kg and the dose is a quarter of what it peaked at.
comment on help me understand 2.4mg, I have read the wiki twice in c/semaglutide · 28 points · 5 months ago
Are you on a pen or research vial? Because the trajectory is different.